The Corner Series Podcast: Site-of-Care Optimization
The Corner Series Podcast: Equipping PE Partners With Services for Success
The Corner Series Podcast: Rooting Out Bad Actors in Private Equity
The Corner Series Podcast: State Regulatory Interventions in Healthcare
The Corner Series Podcast: Proving Private Equity’s Value in Healthcare
The Corner Series Podcast: From Transactions to True Impact
The Corner Series Podcast: Tracking the Fast-Growing Payor Services Market
The Corner Series Podcast: Private Equity Partnerships and Market Trends
The Corner Series Podcast: Shedding Light on Healthcare Compliance
The Corner Series Podcast: Life Sciences Investors: Keep These Developments Top of Mind
12 Days of Regulatory Insights: Day 2 – How AGs Are Shaping Health Care Markets — Regulatory Oversight Podcast
Holiday Gifts in Healthcare: Are You Breaking the Rules?
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 259: The Patient Voice in Clinical Trials with Tom Croce of Jazz Pharmaceuticals
Hospice Insights Podcast - But Am I Set Up for Growth: Corporate and Governance Considerations for Growing Hospice
AI Underwriting Uncovered: Risks, Data, and Liability in Insurance – The Good Bot Podcast
HIPAA vs. HR - Where Privacy Meets Employment: What's the Tea in L&E?
AGG Talks: Government Insight for Life Sciences Leaders | How Medicare Regulations Could Affect Access to Gender-Affirming Care: Implications for Life Sciences Companies
42 CFR Part 2 Final Rule: What’s Changing and What Do You Need to Know? – Diagnosing Health Care Video Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 257: Biogen’s $2B Investment in North Carolina’s RTP with Nicole Murphy
Hospice Insights Podcast - If Only I Knew… Avoiding the Most Common Mistakes with the 855
On November 28, 2025, the U.S. Food and Drug Administration (FDA) withdrew its 2024 proposed rule entitled “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products.” 90 FR 54603. The...more
In October 2025, the FDA released a revised guidance titled, “Expanded Access to Investigational Drugs for Treatment Use—Questions and Answers.” The document updates prior interpretations of 21 C.F.R. Part 312, Subpart I,...more
Key Takeaways: The Supreme Court heard oral arguments in First Choice Women’s Resource Centers v. Platkin, Docket No. 24-781, on December 2, 2025, concerning the administrative subpoena sent by the New Jersey Attorney...more
The IRS has released the 2026 cost-of-living adjustments to certain limits, thresholds and penalties that apply to employee benefits plans and programs. The following charts provide the applicable limits for 2026 in...more
FDA recently issued a new draft guidance titled Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies, which proposes...more
A landmark agreement between the UK government and the US administration guarantees zero tariffs on UK pharmaceutical exports to the United States for at least three years in exchange for commitments from the United Kingdom...more
The U.S. Department of Justice's recent subpoenas and the Hsiao Declaration signal a potential redefinition of enforcement boundaries under the Food, Drug, and Cosmetic Act (FDCA). By asserting that off-label prescribing may...more
As the new legislative year approaches, organizations and stakeholders face a rapidly evolving policy landscape shaped by congressional priorities and executive branch initiatives. It's important to note that the U.S....more
The Centers for Medicare & Medicaid Services (CMS) has announced that the Center for Medicare and Medicaid Innovation (CMMI) is testing an outcome-aligned payment (OAP) approach designed to give Medicare fee-for-service (FFS)...more
Often, people with long-term medical or cognitive conditions that limit their ability to manage their daily care need in-home assistance. Since home care typically costs between $25 and $35 an hour, without long-term care...more
Directs the Department of Health and Human Services (HHS) to modernize the nation's child-welfare system by improving data collection, updating state systems, expanding the use of advanced technology, and publishing annual...more
The Rural Health Transformation (RHT) Program is a five-year, $50 billion initiative established under the One Big Beautiful Bill Act to strengthen healthcare delivery in rural communities....more
California AG Rob Bonta and the City of New York were joined by a bipartisan coalition of 24 AGs in sending a letter to Shopify Inc., urging the company to crack down on merchants using its e-commerce platform to sell illegal...more
The California Department of Health Care Services (“DHCS”) announced via a Policy Letter that the state has paused the application process for Program of All-Inclusive Care for the Elderly (“PACE”) organizations for a minimum...more
Welcome back to the Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, the big news is out of Virginia, where there’s some progress on a retail market bill. Medicare may begin...more
As reported by Bloomberg, the Democratic Attorneys General Association (DAGA) has hired Rohit Chopra, former Director of the Consumer Financial Protection Bureau (CFPB or Bureau), to lead a new Consumer Protection and...more
On November 14, 2025, CMS issued a press release and accompanying letter providing preliminary guidance to states on the implementation of new federal requirements governing health-care-related (i.e., provider) taxes under...more
In this episode of our special 12 Days of Regulatory Insights podcast series, Chris Carlson, a partner in our RISE practice group and member of the State Attorney General (AG) team, is joined by colleagues Lauren Fincher,...more
The Minnesota Department of Human Services (“DHS”) quietly communicated on December 1, 2025, its intent to issue a temporary licensing moratorium for 245D-licensed Home and Community Based Services (“HCBS”), effective January...more
In the labyrinthine world of medical device manufacturing, process is king—but culture wears the crown. Peter Drucker's adage, “Culture eats strategy for breakfast,” has long echoed through boardrooms, but within regulated...more
Key Takeaways: The ACCESS Model1 tests an outcome-aligned payment (OAP) approach designed to give people with Original Medicare new options to improve their health and prevent and manage chronic disease with...more
The U.S. and UK have announced a pharmaceutical tariff and pricing deal in which the UK government agreed to increase investment in innovative medicines, and U.S. President Trump agreed to exempt the UK from certain...more
AI is changing the game in patient care. From wearable sensors that track vitals to predictive alerts that flag early signs of deterioration, these tools are helping clinicians intervene faster and smarter. But here’s the...more
In a recently settled False Claims Act case, the Department of Justice (DOJ) highlighted several alleged practices that offer important lessons for compliance professionals. While the case settled with no admission of...more
On November 28, 2025, while most cosmetic companies were promoting their “Black Friday” deals for this year, the FDA quietly issued a Federal Register notice withdrawing the Agency’s previously proposed regulation for...more
